Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Problems with resistance in pediatric intensive care

P Toltzis1, J L Blumer

  • 1Division of Pediatric Pharmacology, Rainbow Babies and Childrens Hospital, Cleveland OH 44106, USA.

New Horizons (Baltimore, Md.)
|August 1, 1996
PubMed
Summary

Antibiotic resistance in neonatal and pediatric intensive care units (ICUs) requires investigation. Emerging resistant Gram-negative bacteria in PICUs may be community-acquired, necessitating reassessment of control strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose.

Clinical pharmacology and therapeutics·2008
Same author

Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties.

Clinical pharmacology and therapeutics·2007
Same author

Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit.

Minerva pediatrica·2003
Same author

Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux.

Alimentary pharmacology & therapeutics·2002
Same author

Infection control in pediatric hospitals.

Current opinion in infectious diseases·2002
Same author

The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration.

Journal of clinical pharmacology·2002

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pediatric Critical Care

Background:

  • Antibiotic resistance epidemiology in neonatal and pediatric intensive care units (ICUs) is understudied.
  • Patient factors (health status, immune maturity, prior antibiotic exposure) may alter resistance patterns compared to adults.
  • Key concerns include methicillin-resistant Staphylococcus aureus (MRSA) in neonatal ICUs and antibiotic-resistant Gram-negative bacteria in pediatric ICUs (PICUs).

Purpose of the Study:

  • To investigate the unique aspects of antibiotic resistance in neonatal and pediatric intensive care environments.
  • To examine the origins and transmission dynamics of resistant pathogens in these vulnerable patient populations.
  • To evaluate the effectiveness of current infection control and antibiotic stewardship strategies.

Main Methods:

  • Review of existing literature on antibiotic resistance in neonatal and pediatric ICUs.
  • Analysis of epidemiological data concerning resistant pathogens.
  • Assessment of infection control challenges, including personnel colonization and transmission.
  • Evaluation of the impact of antibiotic restriction policies.

Main Results:

  • Methicillin-resistant Staphylococcus aureus (MRSA) outbreaks in neonatal ICUs present significant infection control challenges, particularly concerning nursery personnel.
  • Emergence of antibiotic-resistant Gram-negative bacteria in PICUs is a growing concern.
  • Evidence suggests these Gram-negative pathogens are often imported from the community, not solely due to internal antibiotic practices.

Conclusions:

  • The distinct patient populations in neonatal and pediatric ICUs may lead to different antibiotic resistance profiles compared to adult settings.
  • Current infection control strategies for MRSA in neonatal ICUs need to address personnel colonization.
  • The community origin of resistant Gram-negative bacteria in PICUs challenges the efficacy of internal antibiotic restriction policies and necessitates revised control strategies.

Related Experiment Videos